Patents by Inventor Chan Woong Park

Chan Woong Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11975037
    Abstract: The present specification relates to a composition for preventing, alleviating or treating burnout syndrome, containing a natural extract as an active ingredient. According to one aspect of the present invention, the composition contains a ginseng fruit extract, and thus is useful for preventing, treating and alleviating burnout syndrome. In addition, according to one aspect of the present invention, the composition further contains ginseng fruit and one or more selected from the group consisting of red ginseng, Angelica gigas, Cornus officinalis, Cervi parvum corni, and Nigella sativa, so as to maximize the synergistic effect among two or more ingredients, thereby exhibiting excellent effects on the prevention, treatment and alleviation of burnout syndrome. Therefore, there is an advantage of making individuals and society mentally and physically healthy since burnout syndrome can be prevented, treated and alleviated, by using the composition of the present invention.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: May 7, 2024
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Su-Hwan Kim, Chan-Woong Park, Sun Mi Kim, Juewon Kim, Byung Gyu Kim, Wan Gi Kim, Sang Jun Lee
  • Patent number: 11976975
    Abstract: Provided is an optical system which may acquire a hyperspectral image by acquiring a spectral image of an object to be measured, which includes, to collect spectral data and train the neural network, an image forming part forming an image from an object to be measured and transmitting collimated light, a slit moving to scan the incident image and passing and outputting a part of the formed image, and a first optical part obtaining spectral data by splitting light of the image received through the slit by wavelength. Also, the system includes, to decompose overlapped spectral data and to infer hyperspectral image data through the trained neural network, an image forming part forming an image from an object to be measured and transmitting collimated light, and a first optical part obtaining spectral data by splitting light of the received image by wavelength.
    Type: Grant
    Filed: January 7, 2022
    Date of Patent: May 7, 2024
    Assignee: Electronics and Telecommunications Research Institute
    Inventors: Keo Sik Kim, Kye Eun Kim, Jeong Eun Kim, Hyun Seo Kang, Hyun Jin Kim, Gi Hyeon Min, Si Woong Park, Hyoung Jun Park, Chan Il Yeo, Young Soon Heo
  • Publication number: 20240073416
    Abstract: The present invention relates to an apparatus and method for encoding and decoding an image by skip encoding. The image-encoding method by skip encoding, which performs intra-prediction, comprises: performing a filtering operation on the signal which is reconstructed prior to an encoding object signal in an encoding object image; using the filtered reconstructed signal to generate a prediction signal for the encoding object signal; setting the generated prediction signal as a reconstruction signal for the encoding object signal; and not encoding the residual signal which can be generated on the basis of the difference between the encoding object signal and the prediction signal, thereby performing skip encoding on the encoding object signal.
    Type: Application
    Filed: November 6, 2023
    Publication date: February 29, 2024
    Applicants: Electronics and Telecommunications Research Institute, Kwangwoon University Industry-Academic Collaboration Foundation, Universily-lndustry Cooperation Group of Kyung Hee University
    Inventors: Sung Chang LIM, Ha Hyun LEE, Se Yoon JEONG, Hui Yong KIM, Suk Hee CHO, Jong Ho KIM, Jin Ho LEE, Jin Soo CHOI, Jin Woong KIM, Chie Teuk AHN, Dong Gyu SIM, Seoung Jun OH, Gwang Hoon PARK, Sea Nae PARK, Chan Woong JEON
  • Patent number: 11717012
    Abstract: The present disclosure relates to an emulsion composition containing ginseng seed oil and ginseng berry extract, wherein the composition is a single phase. Whereas the existing composition containing a water-soluble ingredient as a main ingredient has the problem that, when ginseng seed oil is added, formulation stability is decreased as the ginseng seed oil is separated from the water-soluble ingredient, the emulsion composition according to the present disclosure exhibits superior stability because the ginseng seed oil is uniformly mixed with the water-soluble ingredient and separation of the ginseng seed oil from the water-soluble ingredient does not occur fora long period of time.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: August 8, 2023
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Su Hwan Kim, Sangyoul Na, Hyun Woo Jeong, Wanki Kim, Jisung Kim, Chan Woong Park
  • Publication number: 20230165801
    Abstract: According to one aspect, the disclosure provides a composition for coating a tablet, including an alginate, a natural oil, a modified starch, and a cellulose derivative. According to another aspect, the disclosure provides a method for enteric coating of a tablet, including the step of coating a tablet with a composition including an alginate, a natural oil, a lecithin, and a cellulose derivative. The composition for coating a tablet according to an embodiment of the disclosure is safe as a naturally-derived ingredient and has excellent ability of coating because it can effectively coat even the edge of the tablet. In addition, the composition for coating a tablet according to an embodiment of the disclosure can implement an enteric coating, and thus has excellent heartburn suppression effect.
    Type: Application
    Filed: November 28, 2022
    Publication date: June 1, 2023
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Kwanghyun SHIN, Wonkyung CHO, Minjung KWON, Wanki KIM, Chan Woong PARK
  • Patent number: 11642387
    Abstract: Disclosed is a composition for preventing or inhibiting influenza virus infection, containing ginseng berry polysaccharides as active ingredients, and the ginseng berry polysaccharides exhibit an inhibitory effect on influenza virus activity or infection due to specific ingredients and structures and, specifically, have an excellent inhibitory effect on neuraminidase activity.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: May 9, 2023
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Donghyun Cho, Suhwan Kim, Juewon Kim, Chan Woong Park, Dae Bang Seo
  • Publication number: 20230095813
    Abstract: The present disclosure relates to a composition for improving sleep quality, including ?-aminobutyric acid (GABA) or a salt, hydrate or solvate thereof; and at least one of arginine, niacin, and salts, hydrates and solvates thereof. The composition for improving sleep quality may improve the sleep quality by increasing melatonin secretion. In addition, in another aspect, the present disclosure provides a composition for alleviating stress, including ?-aminobutyric acid (GABA) or a salt, hydrate or solvate thereof; and at least one of arginine, niacin, and salts, hydrates and solvates thereof.
    Type: Application
    Filed: September 28, 2022
    Publication date: March 30, 2023
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Changyong MOON, Su Hwan KIM, Jihae LEE, Kyoungmi JUNG, Wonkyung CHO, Wanki KIM, Jong Hwa ROH, Chan WOONG PARK
  • Patent number: 11219653
    Abstract: The specification relates to a composition for enhancing immunity, comprising a ginseng berry polysaccharide as an active ingredient. The composition can increase the expression of cytokines such as IL-6, IL-12, and TNF-? by using ingredients derived from natural products. In addition, the composition can exhibit excellent immunity enhancement effects because of the unique components and structure of a ginseng berry polysaccharide.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: January 11, 2022
    Assignees: AMOREPACIFIC CORPORATION, KYONGGI UNIVERSITY INDUSTRY & ACADEMIA COOPERATION FOUNDATION 1
    Inventors: Suhwan Kim, Juewon Kim, Chan-woong Park, Dae Bang Seo, Donghyun Cho, Kwang Soon Shin, Dae Young Lee
  • Publication number: 20210298339
    Abstract: The present disclosure relates to an emulsion composition containing ginseng seed oil and ginseng berry extract, wherein the composition is a single phase. Whereas the existing composition containing a water-soluble ingredient as a main ingredient has the problem that, when ginseng seed oil is added, formulation stability is decreased as the ginseng seed oil is separated from the water-soluble ingredient, the emulsion composition according to the present disclosure exhibits superior stability because the ginseng seed oil is uniformly mixed with the water-soluble ingredient and separation of the ginseng seed oil from the water-soluble ingredient does not occur fora long period of time.
    Type: Application
    Filed: March 30, 2021
    Publication date: September 30, 2021
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Su Hwan KIM, Sangyoul NA, Hyun Woo JEONG, Wanki KIM, Jisung KIM, Chan Woong PARK
  • Publication number: 20210267242
    Abstract: One aspect of the present disclosure relates to a granular composition containing sugar alcohols and a method for preparing the same. More specifically, according to one aspect of the present disclosure, a granular composition having a particle size of 12 mesh to 60 mesh may be prepared by introducing raw materials containing a high content of sugar alcohols containing (i) xylitol and (ii) erythritol, mannitol or a combination thereof to an extrusion molding granular, and the granular composition has a softly melting texture and has an excellent effect in user's preference and convenience in ingestion.
    Type: Application
    Filed: February 2, 2021
    Publication date: September 2, 2021
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Sukyung Kim, Juyeon Seo, Jinoh Chung, Wanki Kim, Chan Woong Park, Jaehyun Kim, Hyoseung Lee
  • Patent number: 11096921
    Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: August 24, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Hyun Woo Jeong, Su Kyung Kim, Si Young Cho, Chan Woong Park, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Publication number: 20210196776
    Abstract: Disclosed is a composition for preventing or inhibiting influenza virus infection, containing ginseng berry polysaccharides as active ingredients, and the ginseng berry polysaccharides exhibit an inhibitory effect on influenza virus activity or infection due to specific ingredients and structures and, specifically, have an excellent inhibitory effect on neuraminidase activity.
    Type: Application
    Filed: April 26, 2019
    Publication date: July 1, 2021
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Donghyun CHO, Suhwan KIM, Juewon KIM, Chan Woong PARK, Dae Bang SEO
  • Publication number: 20210128660
    Abstract: The specification relates to a composition for enhancing immunity, comprising a ginseng berry polysaccharide as an active ingredient. The composition can increase the expression of cytokines such as IL-6, IL-12, and TNF-? by using ingredients derived from natural products. In addition, the composition can exhibit excellent immunity enhancement effects because of the unique components and structure of a ginseng berry polysaccharide.
    Type: Application
    Filed: January 26, 2018
    Publication date: May 6, 2021
    Inventors: Suhwan KIM, Juewon KIM, Chan-woong PARK, Dae Bang SEO, Donghyun CHO, Kwang Soon SHIN, Dae Young LEE
  • Patent number: 10898535
    Abstract: The present invention relates to a composition for inhibiting and preventing myopathy comprising a bean leaf extract as an active ingredient. More specifically, the composition has an effect of inhibiting the overexpression of Atrogin1 and Murf1 specifically expressed in myocyte and restoring cell activity of myocyte to inhibit and prevent muscle loss by including the extract of bean leaf at stage R6 to R8 during the growth stage of bean.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: January 26, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Young-Gyu Kang, Soo Hyun Kim, Chan Woong Park, Hee Young Jeon
  • Patent number: 10891401
    Abstract: Disclosed is a mobile terminal having a security function. The mobile terminal having a security function according to the present invention comprises: a case unit having a keypad for inputting data; a substrate unit, disposed inside the case unit, having a data input switch part operated by a keypad; and a tamper-resistant unit, disposed between a keypad and the data input switch part, having a tamper-proof conductive track part electrically connected to the substrate unit, wherein the tamper-proof unit includes a switch shielding part for shielding the data input switch part, and a connecting part for connection, connected to the switch shielding part and electrically connected to the substrate unit.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: January 12, 2021
    Assignee: BLUEBIRD INC.
    Inventors: Jang Won Lee, Moon Gyu Hong, Chan Woong Park
  • Patent number: 10692649
    Abstract: A switching power supply device which includes an input filter capacitor and a switching device, includes: a transformer comprising a core of the transformer and a first input winding, the first input winding being wound around the core of the transformer, connected between one terminal of the input filter capacitor and one terminal of the switching device; a first capacitive unit connected between both terminals of the first attenuation winding part of the transformer, and including at least one device including a first capacitor; and a clamp unit configured to limit a peak voltage generated by the first input winding when the switching device is turned off during the switching operation of the switching device, the clamp unit including a rectification diode.
    Type: Grant
    Filed: March 16, 2017
    Date of Patent: June 23, 2020
    Inventor: Chan Woong Park
  • Patent number: 10555983
    Abstract: Provided in the present specification is a composition for brain activation, comprising ginseng fruit extract as an active ingredient. The composition according to the present specification allows an increase in blood flow in the brain and thus has an effect of ameliorating chronic fatigue syndrome. In addition, the composition according to the present specification activates the brain, and as a result, strengthens connectivity strength between the frontal lobe and the occipital lobe and thus has an effect of improving problem-solving accuracy and reducing solving time in the area of cognitive ability. Therefore, the composition according to the present specification can be used as a pharmaceutical composition or a food composition for patients suffering from chronic fatigue syndrome.
    Type: Grant
    Filed: March 27, 2014
    Date of Patent: February 11, 2020
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Hyun Jung Shin, Chan Woong Park, Su Hwan Kim, Dae Bang Seo, Wan Gi Kim, Sang Jun Lee
  • Publication number: 20200000867
    Abstract: The present invention relates to a composition for inhibiting and preventing myopathy comprising a bean leaf extract as an active ingredient. More specifically, the composition has an effect of inhibiting the overexpression of Atrogin1 and Murf1 specifically expressed in myocyte and restoring cell activity of myocyte to inhibit and prevent muscle loss by including the extract of bean leaf at stage R6 to R8 during the growth stage of bean.
    Type: Application
    Filed: September 11, 2019
    Publication date: January 2, 2020
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Byung Gyu Kim, Young-Gyu Kang, Soo Hyun Kim, Chan Woong Park, Hee Young Jeon
  • Patent number: 10383904
    Abstract: The present invention relates to a composition which improves the quality of life of women by containing a ginseng berry extract as an active ingredient, and more specifically, to a composition which promotes the general psychological and physical health of women and improving the sexual function and sex life satisfaction women.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: August 20, 2019
    Assignee: Amorepacific Corporation
    Inventors: Chan Woong Park, Su Hwan Kim, Jeong Hwa Jang, Hyun Jung Shin, Sun Mi Kim, Wan Gi Kim, Sang Jun Lee
  • Patent number: 10342836
    Abstract: The present disclosure relates to a composition containing ginseng fruit extract. The present disclosure also relates to a composition for relieving premenstrual syndrome and menstrual pain, which contains ginseng fruit extract. The composition according to the present disclosure exhibits an effect of relieving or improving the symptoms of premenstrual syndrome and thus can be used as a pharmaceutical composition or a food composition.
    Type: Grant
    Filed: June 19, 2014
    Date of Patent: July 9, 2019
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Su Hwan Kim, Chan Woong Park, Jeong Hwa Jang, Wan Gi Kim, Sang Jun Lee